Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000247334 | SCV000301959 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV001081207 | SCV000623893 | likely benign | Chédiak-Higashi syndrome | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000525039 | SCV001147727 | likely benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | LYST: BP4 |
Illumina Laboratory Services, |
RCV001081207 | SCV001253037 | likely benign | Chédiak-Higashi syndrome | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Al Jalila Children’s Genomics Center, |
RCV001081207 | SCV001984034 | benign | Chédiak-Higashi syndrome | 2020-03-30 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002262861 | SCV002543290 | likely benign | Autoinflammatory syndrome | 2021-03-25 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001081207 | SCV003799768 | uncertain significance | Chédiak-Higashi syndrome | 2022-09-13 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000525039 | SCV005264416 | likely benign | not provided | criteria provided, single submitter | not provided |